Gelesis Holdings, Inc.
Pharmaceutical company · Boston, Massachusetts, United States
Gelesis Holdings, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $575,684 sold in a notice filed in 2022.
Gelesis Holdings at a glance
What does Gelesis Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $575,684 sold (2022).
Frequently asked questions about Gelesis Holdings
Where is Gelesis Holdings headquartered?
Gelesis Holdings, Inc. is headquartered in Boston, Massachusetts, United States.
What does Gelesis Holdings do?
Gelesis Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Gelesis Holdings founded?
The earliest incorporation on record for Gelesis Holdings, Inc. is in 2020, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences